Showing results (101-110 of 183) with videos related to

Sort By:
Pageof 19
Cancer|December 1, 1995
Two embryonal cancers after in vitro fertilizationA Toren, N Sharon, M Mandel, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1996
Carcinoid tumors frequently display genetic abnormalities involving chromosome 11O Jakobovitz, D Nass, L DeMarco, et al.
Medical and Pediatric Oncology|April 1, 1995
Genetic predisposition and cyclophosphamide treatment in a girl with bladder carcinoma?G Kenet, M Mandel, Y Mor, et al.
Cell Death & Disease|December 6, 2014
Analysis of gene expression array in TSC2-deficient AML cells reveals IRF7 as a pivotal factor in the Rheb/mTOR pathwayV Makovski, J Jacob-Hirsch, C Gefen-Dor, et al.
Human Reproduction (Oxford, England)|March 10, 2012
Involvement of the prostate and testis expression (PATE)-like proteins in sperm-oocyte interactionM Margalit, L Yogev, H Yavetz, et al.
The Israel Medical Association Journal : IMAJ|January 17, 2002
Autosomal dominant nephritis with renal failure of non-Alport type: clinical and molecular studiesT Ilan, T Shohat, A Tobar, et al.
Medical and Pediatric Oncology|January 1, 1991
Lack of bcr rearrangement in juvenile chronic myeloid leukemiaA Toren, M Mandel, N Amariglio, et al.
Medical and Pediatric Oncology|January 1, 1993
Favorable response of pediatric AIDS-related Burkitt's lymphoma treated by aggressive chemotherapyY Neumann, A Toren, M Mandel, et al.
American Journal of Respiratory Cell and Molecular Biology|January 1, 1997
Absence of p53 mutations in malignant mesotheliomasO Mor, P Yaron, M Huszar, et al.
American Journal of Hematology|February 24, 2005
Coinheritance of BRCA1 and BRCA2 mutations with Fanconi anemia and Bloom syndrome mutations in Ashkenazi Jewish population: possible role in risk modification for cancer developmentM Koren-Michowitz, E Friedman, R Gershoni-Baruch, et al.
Pageof 19